In pathological states (e.g., cancer), MDM2 is often overexpressed due to chromosomal amplification or mutations in various tumors (e.g., sarcomas, breast cancer, liver cancer, neuroblastoma) [25,26,27,28]. This evidence concerns the gene MDM2 and cancer.